CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleLevered free cash flow is $20M, above the global median of $16.24M
- PositionGross margin is 82.5%, higher than 95% of its Diagnostics & Research peers (median 47%)
- Interpretations16 currently firing — 16
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.46%Above 5Y avg (0.88%)
Annual Rate
CNY 0.45Paid annual
Payout Ratio
33.7%Sustainable
Payback Period
42.2 yr
Last Ex-Dividend
May 18, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
7.16BCNY1.06B · vs all stocks (USD)
Trailing P/E
22.03xvs Diagnostics & Research peers
Revenue (TTM)
1.19BCNY176.14M · vs all stocks (USD)
Profit Margin
30.01%vs Diagnostics & Research peers
Beta
0.3040xvs all stocks
52-Week Change
-24.83%vs all stocks
Market Capitalization
7.16BCNY1.06B · vs all stocks (USD)
Enterprise Value
6.11BCNY906.75M · vs all stocks (USD)
Trailing P/E
22.03xvs Diagnostics & Research peers
Forward P/E
18.95xvs Diagnostics & Research peers
Price to Sales (TTM)
6.23xvs Diagnostics & Research peers
Price to Book (MRQ)
3.57xvs Diagnostics & Research peers
Enterprise to Revenue
5.15xvs Diagnostics & Research peers
Enterprise to EBITDA
13.87xvs Diagnostics & Research peers
Gross Margin
82.46%vs Diagnostics & Research peers
Profit Margin
30.01%vs Diagnostics & Research peers
Operating Margin
38.58%vs Diagnostics & Research peers
Return on Assets (TTM)
10.91%vs Diagnostics & Research peers
Return on Equity (TTM)
17.90%vs Diagnostics & Research peers
Revenue (TTM)
1.19BCNY176.14M · vs all stocks (USD)
Revenue per Share (TTM)
3.00CNYUpdated Aug 19, 2026Quarterly Revenue Growth
-4.30%vs Diagnostics & Research peers
Gross Profit (TTM)
966.08MCNY143.48M · vs all stocks (USD)
EBITDA (TTM)
430.58MCNY63.95M · vs all stocks (USD)
Net Income (TTM)
355.94MCNY52.86M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-5.90%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
368.86MCNY54.78M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
134.65MCNY20.00M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.4500CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
2.46%vs all stocks
5-Year Average Dividend Yield
0.88%vs all stocks
Payout Ratio
33.71%vs Diagnostics & Research peers
Revenue
1.20BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
208.51MCNYFY2025 · Dec 31, 2025Gross Profit
989.22MCNYFY2025 · Dec 31, 2025Operating Income
411.59MCNY61.13M · vs all stocks (USD)
Pre-tax Income
410.92MCNYFY2025 · Dec 31, 2025Income Tax Expense
49.67MCNYFY2025 · Dec 31, 2025Net Income
361.26MCNYFY2025 · Dec 31, 2025EBIT
412.85MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
492.78MCNYFY2025 · Dec 31, 2025Research & Development
177.59MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
374.18MCNYFY2025 · Dec 31, 2025Other Operating Expenses
23.85MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
30.85MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
1.93MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.9100CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.9000CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
396.98MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
396.98MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
361.26MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
263.26MCNYFY2025 · Dec 31, 2025Free Cash Flow
194.88MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
341.54MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
361.26MCNYFY2025 · Dec 31, 2025Other Non-cash Items
12.45MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-105.04MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-5.39MCNYFY2025 · Dec 31, 2025Capital Expenditures
-68.38MCNYFY2025 · Dec 31, 2025Purchase of Investments
-455.50MCNYFY2025 · Dec 31, 2025Sale of Investments
291.98MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-231.90MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
101.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-45.75MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-118.95MCNYFY2025 · Dec 31, 2025Other Financing Charges
-38.00MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-101.70MCNYFY2025 · Dec 31, 2025Shares Outstanding
391.54MSharesUpdated Aug 19, 2026Float Shares
278.52MSharesUpdated Aug 19, 2026% Held by Insiders
32.73%vs all stocks
% Held by Institutions
10.43%vs all stocks
Total Cash (MRQ)
1.43BCNY212.71M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.70CNYUpdated Aug 19, 2026Total Debt (MRQ)
200.49MCNY29.78M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0974xvs Diagnostics & Research peers
Current Ratio (MRQ)
15.14xvs Diagnostics & Research peers
Book Value per Share (MRQ)
5.31CNYUpdated Aug 19, 2026Total Assets
2.35BCNY348.67M · vs all stocks (USD)
Total Current Assets
2.05BCNYFY2025 · Dec 31, 2025Total Liabilities
291.69MCNYFY2025 · Dec 31, 2025Total Non-current Assets
294.70MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
113.57MCNYFY2025 · Dec 31, 2025Total Current Liabilities
178.12MCNYFY2025 · Dec 31, 2025Cash
1.06BCNYFY2025 · Dec 31, 2025Cash Equivalents
2.42MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.07BCNYFY2025 · Dec 31, 2025Other Short-term Investments
275.96MCNYFY2025 · Dec 31, 2025Accounts Receivable
644.94MCNYFY2025 · Dec 31, 2025Inventory
37.34MCNYFY2025 · Dec 31, 2025Accounts Payable
21.95MCNYFY2025 · Dec 31, 2025Short-term Debt
9.44MCNYFY2025 · Dec 31, 2025Other Current Liabilities
204.80KCNYFY2025 · Dec 31, 2025Long-term Debt
99.16MCNYFY2025 · Dec 31, 2025Common Stock (Book)
391.54MCNYFY2025 · Dec 31, 2025Retained Earnings
1.39BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.06BCNY305.35M · vs all stocks (USD)
Treasury Stock
25.45MCNYFY2025 · Dec 31, 202552-Week Low
15.62CNYUpdated Aug 19, 202652-Week High
26.15CNYUpdated Aug 19, 202652-Week Change
-24.83%vs all stocks
Beta
0.3040xvs all stocks
50-Day MA
17.57CNYUpdated Aug 19, 2026200-Day MA
20.44CNYUpdated Aug 19, 2026Avg 10-Day Volume
11.17MSharesUpdated Aug 19, 2026Avg 30-Day Volume
9.41MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.8600CNYUpdated Aug 19, 202616 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Cash Elevated Relative to Current Liabilities and Total Assets
Its cash covers more of its near-term bills than in its industry, and is a large share of everything it owns.
Reads
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How does this company use capital?
Cash Backing With Revenue And Income Streaks
Revenue has risen in each of three years, profit in all three, and it holds more cash than debt.
Reads
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
Three Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion Levels
Its gross margin and its cash margin are high for its industry, and its operating margin is high outright.
Reads
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Three Margin Ratios Elevated Across Gross, Operating, And Net Levels
Its gross and net margins are high for its industry, and its operating margin is high outright.
Reads
Multi-Year FCF With Growth And Margin
Three years of positive free cash flow and rising revenue, four of rising equity, and much of its sales turns into cash.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
Price Below Mean With Profitability And Equity
Price sits well below its yearly mean, profitable three years, and its equity ratio is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 82.5%, higher than 95% of its Diagnostics & Research peers (median 47%)Significant
Gross margin: 0.82Industry median: 0.47Industry P95: 0.80Peers compared: 28.00
Operating margin is 38.6%, higher than 95% of its Diagnostics & Research peers (median 9.9%)Significant
Operating margin: 0.39Industry median: 0.10Industry P95: 0.35Peers compared: 28.00
Profit margin is 30%, higher than 95% of its Diagnostics & Research peers (median 4.5%)Significant
Profit margin: 0.30Industry median: 0.05Industry P95: 0.23Peers compared: 28.00
Current ratio is 15.14×, higher than 95% of its Diagnostics & Research peers (median 2.76×)Significant
Current ratio: 15.14Industry median: 2.76Industry P95: 11.87Peers compared: 28.00
Financial Health
High structural barrier to entryNotable
Barrier to Entry: 0.54
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Levered free cash flow is $20M, above the global median of $16.24MNotable
Levered free cash flow (USD): 19,998,686.135Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Beijing Jingyuntong Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Sansteel Minguang Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Fuji Seal International Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Kunshan Guoli Electronic Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Al Hammadi Holding Company
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Wuzhou Special Paper Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Zhiyang Innovation Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Jiangsu Gian Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Jin Tong Ling Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Kardemir Karabük Demir Çelik Sanayi ve Ticaret A.Ş.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
United States Lime & Minerals Inc.
14 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityCash Backing With Revenue And Income StreaksROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedIndustry-Benchmarked ROA and Margin ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsLow-Leverage Liquidity ConfigurationMulti-Year FCF With Growth And Margin
One Career Inc.
13 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedIndustry-Benchmarked ROA and Margin ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsLow-Leverage Liquidity ConfigurationMulti-Year FCF With Growth And Margin
Shanghai Bochuan Electronic Co., Ltd.
13 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityCash Backing With Revenue And Income StreaksROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthLiquidity Ratios ElevatedIndustry-Benchmarked ROA and Margin ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsLow-Leverage Liquidity ConfigurationMulti-Year FCF With Growth And Margin